Driving Innovation: Drug Patents vs. Prizes
Joseph E Stiglitz, American economist and professor at Columbia University, states that prizes should be favored over patents to reward […]
Joseph E Stiglitz, American economist and professor at Columbia University, states that prizes should be favored over patents to reward […]
This paper was originally published by Hanqing Xue, Jie Li, Haozhe Xie, and Yadong Wang in Int J Biol Sci 2018; 14(10):1232-1244
Review of Drug Repositioning Approaches and Resources Read Post »
This paper was originally published by Glenn P. Carroll, Sanjay Srivastava, Adam S. Volini, Marta M. Piñeiro-Núñez, and TatianaVetman in Drug Discovery
Measuring the effectiveness and impact of an open innovation platform Read Post »
The story of Viagra’s patents and generic entry of sildenafil citrate is a valuable one because it covers many of
Viagra: A Complicated Case Study of Generic Drug Market Entry in the United States Read Post »
Drugs can have many patents and regulatory protections Drugs can be covered by myriad patents and regulatory protections. Even Aspirin,
This is paper was originally published in BioMed Research International, Volume 2016, by Tomas Gabriel Bas and Carolina Oliu Castillo
Although many areas of contention exist in trade relations between the United States and China, ties are strengthening between the
China and Potential Opportunity for Pharmaceutical Investments Read Post »
Headlines about high drug prices are nothing new. The high cost of bringing new drugs to market, plus high merger
Evolving Pharmaceutical Strategies in a Post-Blockbuster World Read Post »
India’s pharmaceutical industry has grown tremendously over the past thirty years and is now the world’s third largest drug producer
Balancing Opportunity and Risk in India’s Pharmaceutical Sector Read Post »
Subscribe to our weekly newsletter below and never miss the latest product or an exclusive offer.